1. Home
  2. WLFC vs VOR Comparison

WLFC vs VOR Comparison

Compare WLFC & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Willis Lease Finance Corporation

WLFC

Willis Lease Finance Corporation

N/A

Current Price

$45.73

Market Cap

983.4M

ML Signal

N/A

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

N/A

Current Price

$19.19

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WLFC
VOR
Founded
1985
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
983.4M
1.1B
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
WLFC
VOR
Price
$45.73
$19.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
10
Target Price
★ $65.50
$39.00
AVG Volume (30 Days)
194.1K
★ 663.2K
Earning Date
11-03-2026
10-30-2026
Dividend Yield
★ 1.29%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 2.86
N/A
Revenue
★ $569,223,000.00
N/A
Revenue This Year
$16.75
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$16.13
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.67
$6.50
52 Week High
$81.54
$26.00

Technical Indicators

Market Signals
Indicator
WLFC
VOR
Relative Strength Index (RSI) 64.51 47.15
Support Level $18.05 $17.62
Resistance Level $48.78 $20.11
Average True Range (ATR) 2.61 1.25
MACD -0.20 0.03
Stochastic Oscillator 71.01 30.33

Price Performance

Historical Comparison
WLFC
VOR

About WLFC Willis Lease Finance Corporation

Willis Lease Finance Corp, with its subsidiaries, is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments, which include Leasing and Related Operations and Spare Parts Sales. A majority of its revenue is generated from the Leasing and Related Operations segment, which involves acquiring and leasing, under operating leases, commercial aircraft, aircraft engines, and other aircraft equipment and the selective purchase and resale of commercial aircraft engines, aircraft equipment, and other related businesses. Geographically, the company derives maximum Lease rent revenue from the United States, followed by Europe, Asia-Pacific (excluding India), India, South America, Canada, Central America, and the Middle East.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: